Lyn Baranowski
CIK: 0001893640
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
AVLN
Avalyn Pharma Inc.
DirectorOfficer
Discretionary Trading P&L
Holdings
About Baranowski Lyn
Baranowski Lyn (SEC CIK 0001893640) files insider reports with the SEC as Chief Executive Officer of Avalyn Pharma Inc. (AVLN).
Signal8 holds 2 ownership filings by Baranowski Lyn (1 Form 3, 1 Form 4), filed between Apr 29, 2026 and May 1, 2026. Those filings report 1 transaction, the latest on Apr 29, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Baranowski Lyn's filings is in BOSTON, MA.
Recent filings by Baranowski Lyn
- Apr 29, 2026: Grant or award of AVLN derivative securities (Form 4, code A).
Other insiders filing for Avalyn Pharma Inc. (AVLN)
- Meyer Robert J., Director
- Novo Holdings A/S, 10% Owner
- FMR LLC, 10% Owner
- Golden Adam H., General Counsel
- Carroll Jill, Director
- SR ONE CAPITAL MANAGEMENT, LLC, 10% Owner